- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- Out-licensing
- View
Granulocyte colony stimulating factor
Mechanism of action
Full description
Fully-developed technology for manufacture of recombinant human granulocyte colony stimulating factor (G-CSF). * High yielding process. * Quality matching branded product. * E. coli based expression. * Product registered in the Indian market. * Clinically well proven. * Unlimited supplies available for bulk and finished product in pre-filled syringes. * Complete product dossier available for registration.
Development status
Patent information
Non-patented technology.
Type of business relationship sought
* Out-licensing of technology for recombinant G-CSF derived from E. coli * Registration of rHu G-CSF in non-regulated markets * Scouting for partners in Europe who will take full responsibility for registering one or more of the following products [Viz.: Recombinant human G-CSF, rIFN-alpha 2b, erythropoietin (EPO)] * Marketing tie-ups .
Licensing contact
Asst General Manager
Business Development
More information
Company details
Research driven, human biotherapeutics company focused on rDNA products offering out-licensing of biogeneric bulk-API and finished formulations, contract research and contract manufacturing services.
Related reports
Related items
- Proton pump inhibitors in cancer therapy
- Pharmaceutical composition based on Mutants created by insertions and deletions of Ezrin
- Universally Applicable Technology for Inactivation of Enveloped Viruses and Other Pathogenic Microorganisms for Vaccine Development
- NatureWise Biotech & Medicals Corporation: New compounds showing cell cycle gene regulation, with implications for new cancer therapies
- Amphora/ACIDFORM Microbicide
Related categories
- Industry sector
- Biotechnology
- Biotechnology / Human therapeutics
- Therapeutic target
- Blood and forming organs
- Cardiovascular / Anemia
- Blood and forming organs / Blood composition / Neutropenia
- Infectious diseases / Diseases / Hepatitis C/D/E
- Infectious diseases / Diseases / Hepatitis A/B
- Oncology / Leukemia
- Oncology / Kaposi's sarcoma
- Oncology / Leukemia / Myelodysplastic syndrome
- Oncology / Leukemia / Multiple myeloma
- Oncology / Cancer side effects / Metastasis
- Oncology / Cancer side effects / Chemotherapy side effects
- Oncology / Leukemia / Acute myeloid leukemia
- Oncology / Treatments / Chemotherapy
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us